2-Methyl-5-oxo-1-cyclopenten-1-yl butyrate
| Common Name: |
2-Methyl-5-oxo-1-cyclopenten-1-yl butyrate |
| IUPAC Name: |
(2-methyl-5-oxocyclopenten-1-yl) butanoate |
| Molecular Formula: |
C10H14O3 |
| SMILES: |
CCCC(=O)OC1=C(CCC1=O)C |
| Inchi: |
1S/C10H14O3/c1-3-4-9(12)13-10-7(2)5-6-8(10)11/h3-6H2,1-2H3 |
| Inchi Key: |
SUJWBOKDKMEAOQ-UHFFFAOYSA-N |
| Cas No: |
68227-51-0 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
182.22 |
| Mass (g/mol) |
182.094 |
| Molar Refractivity |
49.08 |
| Net Charge |
|
| HBD |
|
| HBA |
3 |
| Rt Bonds |
4 |
| Rings |
1 |
| TPSA |
43.37 |
| Hetero Atoms |
3 |
| Heavy Atoms |
13 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
305.00 to 306.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.001 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.60 |
| LogP |
1.967 |
| iLOGP |
2.24 |
| XLOGP3 |
1.24 |
| WLOGP |
1.97 |
| MLOGP |
1.10 |
| ESOL Log S |
-1.49 |
| ESOL Solubility (mg/ml) |
5.94 |
| ESOL Solubility (mol/l) |
0.033 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-1.75 |
| Ali Solubility (mg/ml) |
3.25 |
| Ali Solubility (mol/l) |
0.02 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-2.40 |
| Silicos-IT Solubility (mg/ml) |
0.73 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.53 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.47 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.074 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
